Literature DB >> 15166224

The modular adaptor protein ARH is required for low density lipoprotein (LDL) binding and internalization but not for LDL receptor clustering in coated pits.

Peter Michaely1, Wei-Ping Li, Richard G W Anderson, Jonathan C Cohen, Helen H Hobbs.   

Abstract

ARH is an adaptor protein required for efficient endocytosis of low density lipoprotein (LDL) receptors (LDLRs) in selected tissues. Individuals lacking ARH (ARH-/-) have severe hypercholesterolemia due to impaired hepatic clearance of LDL. Immortalized lymphocytes, but not fibroblasts, from ARH-deficient subjects fail to internalize LDL. To further define the role of ARH in LDLR function, we compared the subcellular distribution of the LDLR in lymphocytes from normal and ARH-/- subjects. In normal lymphocytes LDLRs were predominantly located in intracellular compartments, whereas in ARH-/- cells the receptors were almost exclusively on the plasma membrane. Biochemical assays and quantification of LDLR by electron microscopy indicated that ARH-/- lymphocytes had >20-fold more LDLR on the cell surface and a approximately 27-fold excess of LDLR outside of coated pits. The accumulation of LDLR on the cell surface was not due to failure of receptors to localize in coated pits since the number of LDLRs in coated pits was similar in ARH-/- and normal cells. Despite the dramatic increase in cell surface receptors, LDL binding was only 2-fold higher in the ARH-/- lymphocytes. These findings indicate that ARH is required not only for internalization of the LDL.LDLR complex but also for efficient binding of LDL to the receptor and suggest that ARH stabilizes the associations of the receptor with LDL and with the invaginating portion of the budding pit, thereby increasing the efficiency of LDL internalization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15166224     DOI: 10.1074/jbc.M405242200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  MicroRNA-27a decreases the level and efficiency of the LDL receptor and contributes to the dysregulation of cholesterol homeostasis.

Authors:  M Lucrecia Alvarez; Mahdieh Khosroheidari; Elena Eddy; Stefania C Done
Journal:  Atherosclerosis       Date:  2015-08-20       Impact factor: 5.162

2.  Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia.

Authors:  Christopher Jones; Rita Garuti; Peter Michaely; Wei-Ping Li; Nobuyo Maeda; Jonathan C Cohen; Joachim Herz; Helen H Hobbs
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

3.  Monovalent, reduced-size quantum dots for imaging receptors on living cells.

Authors:  Mark Howarth; Wenhao Liu; Sujiet Puthenveetil; Yi Zheng; Lisa F Marshall; Michael M Schmidt; K Dane Wittrup; Moungi G Bawendi; Alice Y Ting
Journal:  Nat Methods       Date:  2008-04-20       Impact factor: 28.547

4.  Distinct functional domains contribute to degradation of the low density lipoprotein receptor (LDLR) by the E3 ubiquitin ligase inducible Degrader of the LDLR (IDOL).

Authors:  Vincenzo Sorrentino; Lilith Scheer; Ana Santos; Eric Reits; Boris Bleijlevens; Noam Zelcer
Journal:  J Biol Chem       Date:  2011-07-06       Impact factor: 5.157

5.  Identification of roles for H264, H306, H439, and H635 in acid-dependent lipoprotein release by the LDL receptor.

Authors:  Hongyun Dong; Zhenze Zhao; Drake G LeBrun; Peter Michaely
Journal:  J Lipid Res       Date:  2016-11-28       Impact factor: 5.922

Review 6.  PCSK9: From Basic Science Discoveries to Clinical Trials.

Authors:  Michael D Shapiro; Hagai Tavori; Sergio Fazio
Journal:  Circ Res       Date:  2018-05-11       Impact factor: 17.367

7.  Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment.

Authors:  Kara N Maxwell; Edward A Fisher; Jan L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-27       Impact factor: 11.205

8.  The ARH adaptor protein regulates endocytosis of the ROMK potassium secretory channel in mouse kidney.

Authors:  Liang Fang; Rita Garuti; Bo-Young Kim; James B Wade; Paul A Welling
Journal:  J Clin Invest       Date:  2009-10-19       Impact factor: 14.808

Review 9.  Role of the adaptor protein PDZK1 in controlling the HDL receptor SR-BI.

Authors:  Olivier Kocher; Monty Krieger
Journal:  Curr Opin Lipidol       Date:  2009-06       Impact factor: 4.776

10.  The role of calcium in lipoprotein release by the low-density lipoprotein receptor.

Authors:  Zhenze Zhao; Peter Michaely
Journal:  Biochemistry       Date:  2009-08-04       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.